510(k) device
SPECTRALIS with Flex Module
Heidelberg Engineering GmbH · Tomography, Optical Coherence (OBO, Class II) · First FDA decision Oct 11, 2024, newest Oct 11, 2024GlaucomaMacular degeneration and retinal disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
38
Naming "SPECTRALIS"
MAUDE reports
0
Brand "SPECTRALIS", since 2015
PubMed studies
1,719
Mentioning "SPECTRALIS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing SPECTRALIS with Flex Module
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K241163 · Decided Oct 11, 2024 · 168 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "SPECTRALIS", any status and sponsor, newest update first.
- Adaptive Optics Scanning Light Ophthalmoscopy (AOSLO) and Microperimetry (MP) Sub-studyEnrolling by invitation
University of Wisconsin, MadisonAcademic, hospital or other
NCT07747662 · 10 participants (planned) · Start Nov 5, 2026 · Primary completion Feb 2027
Device: Adaptive Optics Scanning Light Ophthalmoscopy; Microperimetry and 1 more · For: Geographic Atrophy
Sites: Madison, Wisconsin
- COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal DiseaseRecruiting
University of Wisconsin, MadisonAcademic, hospital or other
NCT06380075 · 50 participants (planned) · Start Aug 29, 2024 · Primary completion Dec 2026
Device: Spectralis FAF imaging; Optos imaging and 1 more · For: Retinal Disease
Sites: Madison, Wisconsin
- High Resolution Imaging OCT StudyRecruiting
Heidelberg Engineering GmbHNot on our public-company list
NCT07338461 · 97 participants (planned) · Start Mar 13, 2026 · Primary completion Dec 30, 2026
Device: Autofluorescence Imaging; Infrared reflectance imaging and 2 more · For: Normal Eyes; Age Related Macular Degeneration; Diabetic Retinopathy and 1 more
Sites: Milan, Italy
35 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "SPECTRALIS", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OBO
13 reports: 4 malfunction, 9 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "SPECTRALIS"[tiab]. The summary above synthesizes these.
- Photobleaching by Spectralis Fixation Target.
Tomasso L, Benatti L, Carnevali A, et al. · JAMA Ophthalmol · 2016
- Longitudinal Retinal Changes in MOGAD.
Oertel FC, Sotirchos ES, Zimmermann HG, et al. · Ann Neurol · 2022
- Reproducibility and Reliability of Spectralis II OCT Angiography Vascular Measurements.
Pastore MR, Grotto A, Vezzoni F, et al. · Diagnostics (Basel) · 2022
- Anterior segment optical coherence tomography angiography.
Ayres M, Smallwood R, Brooks AM, et al. · J Vis Commun Med · 2019
- Ultra-Widefield Imaging for Pediatric Retinal Disease.
Patel CK, Buckle M · Asia Pac J Ophthalmol (Phila) · 2018Review
- CNN-Based Device-Agnostic Feature Extraction From ONH OCT Scans.
Driessen SJ, van Garderen KA, De Jesus DA, et al. · Transl Vis Sci Technol · 2024Research Support, Non-U.S. Gov't
- Sub-retinal pigment epithelium tubules in non-neovascular age-related macular degeneration.
Fragiotta S, Parravano M, Sacconi R, et al. · Sci Rep · 2022Research Support, Non-U.S. Gov't
- Reliability of Intra-Retinal Layer Thickness Estimates.
Oberwahrenbrock T, Weinhold M, Mikolajczak J, et al. · PLoS One · 2015Meta-Analysis, Research Support, Non-U.S. Gov't
- Reduced Aqueous Humor Outflow Pathway Arborization in Childhood Glaucoma Eyes.
Gupta S, Zhang X, Panigrahi A, et al. · Transl Vis Sci Technol · 2024Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Deep learning-based image quality assessment for optical coherence tomography macular scans: a multicentre study.
Tang Z, Wang X, Ran AR, et al. · Br J Ophthalmol · 2024Multicenter Study, Research Support, Non-U.S. Gov't
- Artifacts in optical coherence tomography.
Chhablani J, Krishnan T, Sethi V, et al. · Saudi J Ophthalmol · 2014
- Deep learning-driven fragment ion series classification enables highly precise and sensitive de novo peptide sequencing.
Klaproth-Andrade D, Hingerl J, Bruns Y, et al. · Nat Commun · 2024Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code OBO.
- SPECTRALIS HRA+OCT and variantsHeidelberg Engineering GmbH · 510(k) 2026
- CIRRUS HD-OCT Model 6000Carl Zeiss Meditec, Inc. · 510(k) 2024
- AnterionHeidelberg Engineering GmbH · 510(k) 2026
- Spectralis HRA + OCT and variantsHeidelberg Engineering GmbH · 510(k) 2018
- 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1 (type: Maestro2)Topcon Corporation · 510(k) 2024
- Tomey Cornea/Anterior Segment OCT (CASIA2)Tomey Corporation · 510(k) 2025
- P200TE (A10700)Optos Plc. · 510(k) 2024
- RESCAN 700, CALLISTO eyeCarl Zeiss Meditec, AG · 510(k) 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.